216 related articles for article (PubMed ID: 19837943)
21. Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.
Winnepenninckx V; Debiec-Rychter M; Beliën JA; Fiten P; Michiels S; Lazar V; Opdenakker G; Meijer GA; Spatz A; van den Oord JJ
Mod Pathol; 2006 Sep; 19(9):1170-80. PubMed ID: 16799481
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
23. YB-1, the E2F pathway, and regulation of tumor cell growth.
Lasham A; Samuel W; Cao H; Patel R; Mehta R; Stern JL; Reid G; Woolley AG; Miller LD; Black MA; Shelling AN; Print CG; Braithwaite AW
J Natl Cancer Inst; 2012 Jan; 104(2):133-46. PubMed ID: 22205655
[TBL] [Abstract][Full Text] [Related]
24. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
25. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
26. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis.
Bernal JA; Luna R; Espina A; Lázaro I; Ramos-Morales F; Romero F; Arias C; Silva A; Tortolero M; Pintor-Toro JA
Nat Genet; 2002 Oct; 32(2):306-11. PubMed ID: 12355087
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo.
Cho-Rok J; Yoo J; Jang YJ; Kim S; Chu IS; Yeom YI; Choi JY; Im DS
Hepatology; 2006 May; 43(5):1042-52. PubMed ID: 16628636
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the pituitary tumor transforming gene induces p53-dependent senescence through activating DNA damage response pathway in normal human fibroblasts.
Hsu YH; Liao LJ; Yu CH; Chiang CP; Jhan JR; Chang LC; Chen YJ; Lou PJ; Lin JJ
J Biol Chem; 2010 Jul; 285(29):22630-8. PubMed ID: 20452981
[TBL] [Abstract][Full Text] [Related]
29. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
30. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional targets for pituitary tumor-transforming gene-1.
Tong Y; Eigler T
J Mol Endocrinol; 2009 Nov; 43(5):179-85. PubMed ID: 19433493
[TBL] [Abstract][Full Text] [Related]
32. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
33. Proteomics evaluation of MDA-MB-231 breast cancer cells in response to RNAi-induced silencing of hPTTG.
Khazaei G; Shamsabadi FT; Yamchi A; Golalipour M; Jhingan GD; Shahbazi M
Life Sci; 2019 Dec; 239():116873. PubMed ID: 31521689
[TBL] [Abstract][Full Text] [Related]
34. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
35. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.
Chesnokova V; Zonis S; Rubinek T; Yu R; Ben-Shlomo A; Kovacs K; Wawrowsky K; Melmed S
Cancer Res; 2007 Nov; 67(21):10564-72. PubMed ID: 17975001
[TBL] [Abstract][Full Text] [Related]
36. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
37. p21(Cip1) restrains pituitary tumor growth.
Chesnokova V; Zonis S; Kovacs K; Ben-Shlomo A; Wawrowsky K; Bannykh S; Melmed S
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17498-503. PubMed ID: 18981426
[TBL] [Abstract][Full Text] [Related]
38. Pituitary tumor transforming gene 1 regulates Aurora kinase A activity.
Tong Y; Ben-Shlomo A; Zhou C; Wawrowsky K; Melmed S
Oncogene; 2008 Oct; 27(49):6385-95. PubMed ID: 18663361
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
40. Aberrant regulation of survivin by the RB/E2F family of proteins.
Jiang Y; Saavedra HI; Holloway MP; Leone G; Altura RA
J Biol Chem; 2004 Sep; 279(39):40511-20. PubMed ID: 15271987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
